Deep Learning for Echo Analysis, Tracking, and Evaluation of Mitral Regurgitation (DELINEATE-MR)
Aaron S. Long(Columbia University Irving Medical Center), Timothy J. Poterucha(Mayo Clinic), Chris R. Kelsey(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Thomas Mawson(Mount Sinai Hospital), Christopher M. Haggerty(Geisinger Medical Center), Dustin N. Hartzel(Geisinger Health System), Daniel Rocha(Presbyterian Hospital), Martin Leon(Mount Sinai Hospital), Eamon Duffy, Deepa Kumaraiah(NewYork–Presbyterian Hospital), Andrew J. Einstein(NewYork–Presbyterian Hospital), Pierre Elias(Columbia University Irving Medical Center), Vratika Agarwal(Columbia University Irving Medical Center), Rebecca T. Hahn(Columbia University Irving Medical Center), David P. vanMaanen(Geisinger Medical Center), Mathew S. Maurer(Boston University), A. Keivani(Presbyterian Hospital), Jeffrey Ruhl(New York Hospital Queens), Gil Metser(Mount Sinai Hospital), Mark Lebehn(Columbia University Irving Medical Center), Qi Liu(Columbia University Irving Medical Center), Linyuan Jing(Geisinger Medical Center), Joshua Finer(New York Hospital Queens), Shunichi Homma(The Neurological Institute), Ashley Beecy(Presbyterian Healthcare Services)
Cited by 51
Related Papers
Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale
|Circulation|2002|949
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure
|Nature Communications|2020|924
Patent Foramen Ovale as a Risk Factor for Cryptogenic Stroke
|Annals of Internal Medicine|1992|601
Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm
|New England Journal of Medicine|2012|580
Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2024|453